Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $397.4800 (-1.75%) ($397.0200 - $410.6400) on Fri. Nov. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.74% (three month average) | RSI | 69 | Latest Price | $397.4800(-1.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 9.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(49%) XBI(45%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -1.37% in a week (0% probabilities). VIXM(-8%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.37% (StdDev 2.74%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
5 Day Moving Average | $419.06(-5.15%) | 10 Day Moving Average | $409.62(-2.96%) | 20 Day Moving Average | $382.35(3.96%) | To recent high | -10.6% | To recent low | 18.3% | Market Cap | $42.144b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |